Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Statistics

Total Valuation

NERV has a market cap or net worth of $26.85 million. The enterprise value is $74.57 million.

Market Cap	26.85M
Enterprise Value	74.57M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

NERV has 6.99 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	28.50%
Float	5.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.87

Current Ratio	4.87
Quick Ratio	4.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-25.82%
Return on Invested Capital (ROIC)	-28.71%
Return on Capital Employed (ROCE)	-57.61%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.34% in the last 52 weeks. The beta is -0.41, so NERV's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	+75.34%
50-Day Moving Average	3.52
200-Day Moving Average	2.24
Relative Strength Index (RSI)	51.02
Average Volume (20 Days)	80,116

Short Selling Information

The latest short interest is 312,558, so 4.47% of the outstanding shares have been sold short.

Short Interest	312,558
Short Previous Month	407,275
Short % of Shares Out	4.47%
Short % of Float	5.75%
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	-5.57M
Operating Income	-14.64M
Pretax Income	-14.03M
Net Income	-14.03M
EBITDA	-14.64M
EBIT	-14.64M
Earnings Per Share (EPS)	-$1.85

Balance Sheet

The company has $12.29 million in cash and $60.00 million in debt, giving a net cash position of -$47.71 million or -$6.82 per share.

Cash & Cash Equivalents	12.29M
Total Debt	60.00M
Net Cash	-47.71M
Net Cash Per Share	-$6.82
Equity (Book Value)	-34.58M
Book Value Per Share	-4.94
Working Capital	10.35M

Cash Flow

Operating Cash Flow	-14.20M
Capital Expenditures	n/a
Free Cash Flow	-14.20M
FCF Per Share	-$2.03

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	-52.24%
FCF Yield	-52.87%

Analyst Forecast

The average price target for NERV is $4.00, which is 4.17% higher than the current price. The consensus rating is "Hold".

Price Target	$4.00
Price Target Difference	4.17%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	45.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a